ALLMedicine™ Drug Eruptions Center
Research & Reviews 111 results
Clinics in Dermatology; Spaulding RT, Owen CE et. al.
Jul 18th, 2021 - Cutaneous adverse drug reactions produce a significant clinical, financial, and psychological burden on our healthcare industry. The importance of considering a drug reaction in the cause of any dermatitis is underscored by the diversity of clinic...
Clinical Reviews in Allergy & Immunology; Zhang J, Lei Z et. al.
Jul 18th, 2021 - Adverse drug reactions involving the skin are commonly known as drug eruptions. Severe drug eruption may cause severe cutaneous adverse drug reactions (SCARs), which are considered to be fatal and life-threatening, including Stevens-Johnson syndro...
The Medical Clinics of North America; Owen CE, Jones JM
Jun 2nd, 2021 - Severe cutaneous adverse reactions to medications (SCARs) include drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, toxic epidermal necrolysis, and acute generalized exanthematous pustulosis. They are all non-immunog...
Journal of Basic and Clinical Physiology and Pharmacology; Kashyap A, Sreenivasan S et. al.
Mar 17th, 2021 - Ciprofloxacin (CIPRO) is a fluroquinolone class antibiotic used commonly for the treatment of various acute and chronic bacterial infections. However, recently there is increase in the case reports of CIPRO-induced Cutaneous Adverse Drug Reactions...
https://doi.org/10.1007/s40257-021-00586-8 10.1097/MJT.0000000000001071 10.1016/j.jaad.2020.05.015 10.1136/bcr-2012-008001
American Journal of Clinical Dermatology; Blum AE, Burgin S
Feb 16th, 2021 - Eczematous drug eruptions are a heterogenous group of skin reactions that resemble eczema both clinically and histologically. We reviewed the literature and cataloged the systemically administered medications that cause these eruptions, along with...
Drugs 9 results see all →
News 22 results
Jacqueline Lin Bucher, MD, Mehwish Ahmed, MD
Oct 7th, 2019 - The Diagnosis: Fracture Blisters The shave biopsy pathology demonstrated a subepidermal bulla with re-epithelialization that was clinically consistent with fracture blisters (also known as fracture bullae)(Figure). Fracture blisters are a complica.
Aug 14th, 2018 - Photo by Larry Young Youn Kim, MD Mogamulizumab is an effective treatment option for relapsed/refractory cutaneous T-cell lymphoma (CTCL), according to researchers. In the phase 3 MAVORIC trial, mogamulizumab prolonged progression-free survival (P.
The Journal of Family Practice;
Jul 2nd, 2018 - Atopic dermatitis is characterized by symmetric involvement of the flexural surfaces of the body with a pruritic, erythematous rash that may have a fine scale. 3 It usually manifests prior to 2 years of age, is recurrent, and is commonly associate.
Feb 5th, 2018 - Photo by Larry Young Youn H. Kim, MD LA JOLLA, CA—Mogamulizumab is a valuable new therapeutic option for patients with cutaneous T-cell lymphoma (CTCL), according to researchers.
The Journal of Family Practice;
Mar 30th, 2017 - The linear pattern of the vesicles and their distribution on the patient’s arms prompted the family physician (FP) to suspect that this was a case of allergic contact dermatitis (ACD) caused by exposure to a plant. While drug eruptions can cause a.